BridgeBio Pharma Inc (NASDAQ:BBIO)

Delayed Data
As of Aug 12
 +0.72 / +6.62%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for BridgeBio Pharma Inc have a median target of 23.50, with a high estimate of 32.00 and a low estimate of 17.00. The median estimate represents a +102.59% increase from the last price of 11.60.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in BridgeBio Pharma Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1,201.65%
Growthannually 13.09%


Growthquarterly -88.30%
Growthannually 8.39%
Key to the earnings and sales forecast charts.